chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Fibrin D dimer, Headache, Hepatic steatosis, Lung opacity
Clinical narrative: Narrative:  03/29, Pfizer, dose #1 04/16, Pfizer, dose #2 07/21 CXR impression: No evidence of an acute process. Clear lungs. 10/04 pt cc:cough, fatigue, fever, headache, loss of taste or smell, myalgias, dyspnea, sore throat exposure: unknown 08/06 COVID swab, result: not detected 10/07 COVID swab, result: not detected 10/13 SARS-COV-2 Variant Sequencing resut: pending 10/13 COVID swab, result: detected 10/15 pt admit ED cc: "intermittent coughing and some bilateral upper (non mid line) back pain (thoracic region, not over where his kidneys are)" dx: COVID 19 LOS: 1 day 10/15 procalcitonin: 0.10 10/15 ddimer: 0.50 10/15 CXR impression: New left lung base opacity, suspicious for pneumonia. 10/15 CTA PE impression: Impression:1. No CT evidence of a large central pulmonary embolism. 2. Diffuse ground glass opacities involving the bilateral lower lobes and right upper lobe. Finding may be consistent with the patient's positive COVID status. 3. Atherosclerosis. 4. Hepatic steatosis. Total DLP (mGy*cm): 424.4 10/19 clinically resolved 10/28 10/28 COVID swab, result: detected
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Oropharyngeal pain, Procalcitonin increased, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Narrative:  03/29, Pfizer, dose #1 04/16, Pfizer, dose #2 07/21 CXR impression: No evidence of an acute process. Clear lungs. 10/04 pt cc:cough, fatigue, fever, headache, loss of taste or smell, myalgias, dyspnea, sore throat exposure: unknown 08/06 COVID swab, result: not detected 10/07 COVID swab, result: not detected 10/13 SARS-COV-2 Variant Sequencing resut: pending 10/13 COVID swab, result: detected 10/15 pt admit ED cc: "intermittent coughing and some bilateral upper (non mid line) back pain (thoracic region, not over where his kidneys are)" dx: COVID 19 LOS: 1 day 10/15 procalcitonin: 0.10 10/15 ddimer: 0.50 10/15 CXR impression: New left lung base opacity, suspicious for pneumonia. 10/15 CTA PE impression: Impression:1. No CT evidence of a large central pulmonary embolism. 2. Diffuse ground glass opacities involving the bilateral lower lobes and right upper lobe. Finding may be consistent with the patient's positive COVID status. 3. Atherosclerosis. 4. Hepatic steatosis. Total DLP (mGy*cm): 424.4 10/19 clinically resolved 10/28 10/28 COVID swab, result: detected
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, Headache, International normalised ratio normal, Nausea
Clinical narrative: 3/29, Pfizer, dose #1 04/19, Pfizer, dose #2 09/03 pt/inr 12/1 07  09/28 pt cc: headache, nausea, vomiting, fatigue exposure: unknown 10/13 COVID swab, result: detected 10/17 clinically resolved 11/08 pt/inr 11.5/1.03 11/08 COVID swab, result: detected
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Prothrombin time normal, SARS-CoV-2 test positive, Vomiting
Clinical narrative: 3/29, Pfizer, dose #1 04/19, Pfizer, dose #2 09/03 pt/inr 12/1 07  09/28 pt cc: headache, nausea, vomiting, fatigue exposure: unknown 10/13 COVID swab, result: detected 10/17 clinically resolved 11/08 pt/inr 11.5/1.03 11/08 COVID swab, result: detected
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Diarrhoea, Fatigue, Headache
Clinical narrative: COVID following COVID vaccine series 03/19 COVID vaccine dose #1 04/08 COVID vaccine dose #2 07/01 reported start of "sinus symptoms" 07/12 presented to PCP with c/o nasal congestion, low grade fever, tiredness, diarrhea, post nasal drip, treated for lower respiratory tract infection since 07/01 07/15 reports testing positive for COVID with home kit, c/o cough, diarrhea, fatigue, fever, headache, myalgia, rhinorrhea 09/28 Influenza vaccine from non-VA pharmacy 10/3 COVID test for pre-procedure, tested POSITIVE for COVID, asymptomatic 10/04 clinical resolution for COVID d/t asymptomatic, likely persistent positive from previous infection
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Lower respiratory tract infection, Myalgia, Nasal congestion, Pyrexia, Rhinorrhoea
Clinical narrative: COVID following COVID vaccine series 03/19 COVID vaccine dose #1 04/08 COVID vaccine dose #2 07/01 reported start of "sinus symptoms" 07/12 presented to PCP with c/o nasal congestion, low grade fever, tiredness, diarrhea, post nasal drip, treated for lower respiratory tract infection since 07/01 07/15 reports testing positive for COVID with home kit, c/o cough, diarrhea, fatigue, fever, headache, myalgia, rhinorrhea 09/28 Influenza vaccine from non-VA pharmacy 10/3 COVID test for pre-procedure, tested POSITIVE for COVID, asymptomatic 10/04 clinical resolution for COVID d/t asymptomatic, likely persistent positive from previous infection
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Sinus disorder, Upper-airway cough syndrome
Clinical narrative: COVID following COVID vaccine series 03/19 COVID vaccine dose #1 04/08 COVID vaccine dose #2 07/01 reported start of "sinus symptoms" 07/12 presented to PCP with c/o nasal congestion, low grade fever, tiredness, diarrhea, post nasal drip, treated for lower respiratory tract infection since 07/01 07/15 reports testing positive for COVID with home kit, c/o cough, diarrhea, fatigue, fever, headache, myalgia, rhinorrhea 09/28 Influenza vaccine from non-VA pharmacy 10/3 COVID test for pre-procedure, tested POSITIVE for COVID, asymptomatic 10/04 clinical resolution for COVID d/t asymptomatic, likely persistent positive from previous infection
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative: 01/14, Pfizer, dose #1 02/04, Pfizer, dose #2 11/10, Pfizer, dose #3 09/10 COVID swab, result: not detected 10/12 pt cc: exposure: unknow 10/12 COVID swab, result: detected 10/12 SARS-COV-2 Variant Sequencing result: pending 10/26 COVID swab, result: not detected.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Anosmia, COVID-19, Chills, Cough, Diarrhoea
Clinical narrative: Narrative: 03/25, Moderna , dose #1 04/22, Moderna , dose #2 03/12 COVID swab, result: not detected 10/10 pt cc: fever, cough, chill, loss of smell, dyspnea, diarrhea, fatigue, headach, myalgias, rhinorrhea, sore throat exposure: unknown 10/13 COVID swab, result: detected 10/13 SARS-COV-2 Variant Sequencing result: pending
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Headache, Myalgia, Oropharyngeal pain
Clinical narrative: Narrative: 03/25, Moderna , dose #1 04/22, Moderna , dose #2 03/12 COVID swab, result: not detected 10/10 pt cc: fever, cough, chill, loss of smell, dyspnea, diarrhea, fatigue, headach, myalgias, rhinorrhea, sore throat exposure: unknown 10/13 COVID swab, result: detected 10/13 SARS-COV-2 Variant Sequencing result: pending
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: 03/25, Moderna , dose #1 04/22, Moderna , dose #2 03/12 COVID swab, result: not detected 10/10 pt cc: fever, cough, chill, loss of smell, dyspnea, diarrhea, fatigue, headach, myalgias, rhinorrhea, sore throat exposure: unknown 10/13 COVID swab, result: detected 10/13 SARS-COV-2 Variant Sequencing result: pending
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: Narrative:  01/20, Moderna, dose #1 02/16, Moderna , dose #2 11/03, Moderna , dose #3 10/04 pt cc: dyspnea, cough exposure: unknown 10/12 COVID swab, result: detected 10/14 clinically resolved
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Myalgia Narrative:
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Myalgia, Pain, Pyrexia
Clinical narrative: Myalgia, Fever, LOW GRADE FEVER, CHILLS, DECREASED APPETITIE, BODY ACHES Narrative:
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Neck pain, Pain in extremity
Clinical narrative: Myalgia arm soreness, headache, neck pain  Narrative: NA
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: left arm injection site is red, swollen and painful
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Erythema multiforme, Fatigue, Neck pain, Rash
Clinical narrative: Rash, ErythemaMultiform, neck aches, fatigue, chills
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Back pain, Blood pressure increased, Chest pain, Dizziness
Clinical narrative: Dizziness, Headache, Myalgia, Arthralgia & HYPERtension Narrative: Patient received Booster Moderna Vaccine on 11/17/2021 and reported adverse side effects on 11/19/2021 when the SE became more severe. Onset of headache on 11/17/2021 neck and back pain on 11/18/2021 and headache worsened on 11/19/2021. SE reported directly to VAERS on 11/19/2021. Patient reported worsening symptoms on 11/20-21/2021 resulting in Emergency Room visit. SE at the time were Headaches, Chest Pain, Elevated Blood Pressure. Symptoms improved but currently as of 11/26/2021 Patient with continued malaise, dizziness and fatigue.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Headache, Hypertension, Malaise, Myalgia
Clinical narrative: Dizziness, Headache, Myalgia, Arthralgia & HYPERtension Narrative: Patient received Booster Moderna Vaccine on 11/17/2021 and reported adverse side effects on 11/19/2021 when the SE became more severe. Onset of headache on 11/17/2021 neck and back pain on 11/18/2021 and headache worsened on 11/19/2021. SE reported directly to VAERS on 11/19/2021. Patient reported worsening symptoms on 11/20-21/2021 resulting in Emergency Room visit. SE at the time were Headaches, Chest Pain, Elevated Blood Pressure. Symptoms improved but currently as of 11/26/2021 Patient with continued malaise, dizziness and fatigue.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Neck pain
Clinical narrative: Dizziness, Headache, Myalgia, Arthralgia & HYPERtension Narrative: Patient received Booster Moderna Vaccine on 11/17/2021 and reported adverse side effects on 11/19/2021 when the SE became more severe. Onset of headache on 11/17/2021 neck and back pain on 11/18/2021 and headache worsened on 11/19/2021. SE reported directly to VAERS on 11/19/2021. Patient reported worsening symptoms on 11/20-21/2021 resulting in Emergency Room visit. SE at the time were Headaches, Chest Pain, Elevated Blood Pressure. Symptoms improved but currently as of 11/26/2021 Patient with continued malaise, dizziness and fatigue.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Cardio-respiratory arrest, Condition aggravated, Dizziness, Dyspnoea, Electrocardiogram ST-T change
Clinical narrative: Narrative:  Chief Complaint: 73 yr old male c/o being dizzy 30 mins after Covid-19 booster, BP 180/110 and EKG changes suggestive of inferior-lateral changes. Code blue initiated after Pt at facility d/t hypertensive event -- leading Pt to Hospitalization where evaluated for cardiac causes. Code Blue Note: "FOCUSED HPI: 73 year old male patient with h/o of HTN, DM, who today had his Moderna COVID-19 booster shot, then 30 mins later felt dizzy while pick up meds in Pharmacy. A code blue was called. When code team arrived he was found to have a BP - 189/110 mmHg, HR - 64/min, T-97.9 and EKG showed a SR with interior ischemic ST/Tw changes. On further questioning he reported some mild sob, HA and that he was being w/u by a Cardiologist for a heart condition. A repeat BP was 200 mm/Hg. He was placed on NC O2, PIID placed, ASA 81 mg x 4 given and 911 called."
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Electrocardiogram abnormal, Headache, Hypertension, Ischaemia, Sinus rhythm
Clinical narrative: Narrative:  Chief Complaint: 73 yr old male c/o being dizzy 30 mins after Covid-19 booster, BP 180/110 and EKG changes suggestive of inferior-lateral changes. Code blue initiated after Pt at facility d/t hypertensive event -- leading Pt to Hospitalization where evaluated for cardiac causes. Code Blue Note: "FOCUSED HPI: 73 year old male patient with h/o of HTN, DM, who today had his Moderna COVID-19 booster shot, then 30 mins later felt dizzy while pick up meds in Pharmacy. A code blue was called. When code team arrived he was found to have a BP - 189/110 mmHg, HR - 64/min, T-97.9 and EKG showed a SR with interior ischemic ST/Tw changes. On further questioning he reported some mild sob, HA and that he was being w/u by a Cardiologist for a heart condition. A repeat BP was 200 mm/Hg. He was placed on NC O2, PIID placed, ASA 81 mg x 4 given and 911 called."
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Oedema peripheral
Clinical narrative: Pain/aching and swelling under left armpit and surrounding area Narrative:
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: 73yo oncology patient died on 10/10/2021. Pt with problem list below: History of antineoplastic chemotherapy (ulnar neuropathy of right arm (SCT 292651000119108) Marginal zone lymphoma (SCT 447100004) Smokes tobacco daily (SCT 449868002) Abnormal findings on diagnostic imaging ENCOUNTER FOR DENTAL EXAMINATION AND CLEANING WITHOUT ABNORMAL FINDINGS (ICD-10-CM Z01.20) CHRONIC PERIODONITITS, GENERALIZED, UNSPNeuropathy (SCT 386033004) Clostridium difficile diarrhea (SCT 5891Vitamin D deficiency (SCT 34713006) Benign essential hypertension (SCT 12010Adjustment disorder with mixed emotional features (SCT 55668003) Posttraumatic stress disorder (SCT 47505Chest pain at rest (SCT 9267009) Ulnar neuropathy (SCT 359837005) Chronic obstructive lung disease (SCT 13645005) Osteoarthritis, unspecified whether geneDiabetes mellitus (SCT 73211009) Respiratory Insufficiency (ICD-9 518.Refractive Errors (ICD-9-CM 367.9) Depressive Disorder NOS (ICD-9-CM 311.) Diabetes Mellitus Type II or unspecified (ICD-9-CM 250.00) Basal cell carcinoma - primary (AO) (ICDHyperlipidemia (SCT 55822004) Osteoarthrosis, localized, primary, invoSkin Lesion (ICD-9-CM 709.9) Non-Hodgkin's lymphoma (clinical) (SCT 1) Pt had received covid vaccines on 2/14/21 & 3/13/21. Death is not related to covid vaccines given pt's cancer diagnosis, advanced age and long time distance between death and vaccine admin dates.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Diarrhoea, Fatigue
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/14, Moderna , dose #1 02/12, Moderna , dose #2 10/20 pt cc: chills, cough, diarrhea, fatigue, exposure: unknown 10/26 COVID swab, result: detected
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/14, Moderna , dose #1 02/12, Moderna , dose #2 10/20 pt cc: chills, cough, diarrhea, fatigue, exposure: unknown 10/26 COVID swab, result: detected
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Injection site pain, Myalgia
Clinical narrative: Headache, Myalgia, chills, fatigue, pain injection site Narrative:
Age: 97.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Death, Decreased appetite
Clinical narrative: Narrative:  97yo male patient dised in community nursing home. Pt had received covid vaccines on 1/12/21 & 2/23/21. This patient was a 97 y/o male with pMHx: chronic pancreatitis, gallstones, chronic thrombocytopenia, CVA, HLD, GERD, hypothyroidism, chronic anemia, meleanoma s/p excision, impaired hearing with a history of generalized weakness, decreased appetite before transferred to NH on 7/6/2021. Likely pt's death is not related to covid vaccines given pt's advanced age, comorbidities, and long length of time between death & date of vaccine administrations.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/11, Pfizer, dose #1 04/01, Pfizer, dose #2 10/26, Pfizer, dose #2 10/25 COVID swab, result: detected 10/25 pt cc: exposure: unknown
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Exposure to SARS-CoV-2, Myalgia, Rhinorrhoea
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/17 Janssen, dose #1 (non-facility) 08/06 COVID swab, result: detected 08/06 pt cc: cough, myalgias, rhinorrhea, exposure: COVID-19+ son 08/11 clinically resolved 08/12 SAR-COV-2 LINEAGE result: B.1.617.2 08/12 SARS-COV-2 CLADE results: 21A Delta
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/17 Janssen, dose #1 (non-facility) 08/06 COVID swab, result: detected 08/06 pt cc: cough, myalgias, rhinorrhea, exposure: COVID-19+ son 08/11 clinically resolved 08/12 SAR-COV-2 LINEAGE result: B.1.617.2 08/12 SARS-COV-2 CLADE results: 21A Delta
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Coronary artery disease, Death, Gastrooesophageal reflux disease, Insomnia
Clinical narrative: Narrative: 73 yo pt in hospice care died at home in home hospice on 10/1/21. Pt had received covid vaccines from outside source-no infor provided. Pt's active problem prior to transfer to hospice case: CAD - Coronary artery disease (SCT 53741008) 05/20/2021 (ICD-10-CM I25.10) Insomnia (SCT 193462001) (ICD-10-CM G47.00) 05/20/2021 GERD - Gastro-esophageal reflux disease (SCT 5/20/2021 235595009) (ICD-10-CM K21.9) AF - Atrial fibrillation (SCT 49436004) 03/05/2021 (ICD-10-CM I48.91) WPW - Wolff-Parkinson-White syndrome (SCT 03/05/2021 74390002) (ICD-10-CM I45.6) Pancytopenia (SCT 127034005) (ICD-10-CM D61.818) 03/05/2021 Tricuspid regurgitation (SCT 111287006) 03/05/2021 (ICD-10-CM I07.1) Deficiency of folic acid (SCT 190633005) 03/05/2021 (ICD-10-CM E53.8) Iron deficiency (SCT 35240004) (ICD-10-CM E61.1) 03/05/2021 Seen by palliative care medicine service (SCT 01/06/2021 305824005) (ICD-10-CM Z51.5), Onset 12/30/2020 Obstructive sleep apnea of adult (SCT 11/06/2020 1101000119103) (ICD-10-CM G47.33) Bilateral osteoarthritis of knees (SCT 11/03/2020 112981000119107) (ICD-10-CM M17.0) Reduced mobility (SCT 8510008) (ICD-10-CM 11/03/2020 Z74.09) Essential Hypertension (SCT 38341003) (ICD-10-CM 11/03/2020 I10.) Vascular Dementia, uncomplicated (SCT 429998004) 11/30/2020 (ICD-10-CM F01.51) Posttraumatic Stress Disorder (ICD-9-CM 309.81) 08/13/2014 Bipolar Disorder, unspecified (SCT 13746004) 11/03/2020 (ICD-10-CM F31.9) Basal Cell Carcinoma of Skin, site unspecified 08/13/2014 (ICD-9-CM 173.91) Benign Localized Hyperplasia of Prostate without 11/03/2020 Urinary obstruction and other lower Urinary Tract Symptoms (Luts) (SCT 266569009) (ICD-10-CM N40.1) Allergic rhinitis (ICD-9-CM 477.9) 08/13/2014 Other Ulcerative Colitis (SCT 64766004) 11/03/2020 (ICD-10-CM K51.90) Nonspecific abnormal results of function study 08/13/2014 of liver (ICD-9-CM 794.8) Likely death not related to vaccines given pt was in hospice care when died.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Malaise
Clinical narrative: Narrative:  60yo with HIV infection had been hospitalized since 08/2021 and not doing well. Was transfered to long-term community care rehab (nursing home) facility around 11/1/2021 based on social worker notes (exact date of transfer not specified). Pt died at facility on 11/10/21. Pt had received covid vaccines on 2/18/21 & 3/29/21. death is not related to covid vaccines.
Age: 96.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiogenic shock, Death
Clinical narrative: Narrative:  96yo male patient died while inpatient hospice on 11/10/2021. Death was caused by: Cardiogenic shock. Patient had received covid vaccines on 2/14/2021 & 03/13/2021. Death is not related to covid vaccines.
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebral infarction, Death
Clinical narrative: Narrative:  90yo patient in home hospice care died at home on 11/12/2021. Pt's Hospice Diagnoses: Cerebral Infarction w/ hx of CAD. Pt had received covid vaccines on 5/26/21 & 6/16/21. Death is not related to covid vaccines.
Age: 94.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  94yo male patient who resided in nursing home moved to facility hospice care on 10/21/2021. Pt died on 11/1/2021. Pt's problem list below: 11 Active Problems PROBLEM LAST MOD PROVIDER Osteoarthritis of knee (SCT 239873007) 08/02/2017 (ICD-10-CM M17.0) Benign prostatic hypertrophy without outflow 08/01/2016 obstruction (SCT 254902007) (ICD-10-CM N40.1) Degeneration of cervical intervertebral disc 07/30/2015 (ICD-9-CM 722.4) (ICD-9-CM V45.81); Postsurgical Aortocoronary 05/02/2006 Bypass Status (ICD-9-CM V45.81) (ICD-9-CM 562.10); DIVERTICULOSIS OF COLON 05/08/2003 (ICD-10-CM I25.10); Coronary artery disease 8/01/2016 (SNOMED CT 53741008) (ICD-10-CM I10.); Benign essential hypertension 08/01/2016 (SNOMED CT 1201005) (ICD-10-CM K21.9); Gastroesophageal reflux 08/01/2016 disease (SNOMED CT 235595009) (ICD-9-CM 607.84); IMPOTENCE, ORGANIC ORIGN 05/13/2002 (ICD-10-CM E78.2); Mixed hyperlipidemia (SNOMED 08/01/2016 CT 267434003) (ICD-9-CM 715.00); OSTEOARTHROSIS, GENERALIZED 05/13/2002 Pt had been given covid vaccines on 1/12/21 & 2/9/21. Likely pt's death is not related to covid vaccines given pt's advanced age, comorbidies, and long length of time between death & date of vaccine administrations.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Cerebral haemorrhage, Cerebral venous sinus thrombosis, Fall, Musculoskeletal disorder
Clinical narrative: Narrative:  Event occurred ~9 weeks post patient's booster (third) dose of Pfizer vaccine. This was in a 58 y/o M with a pmhx sig for bladder cancer, sinus node dysfunction s/p pacemaker implantation. Patient presented to ER after describing an episode of "legs giving out" and falling on three occasions". After workup was found to have right frontal/parietal lobe intraparenchymal hemorrhage 2/2 to cerebral sinus thrombosis. Patient relatively stable and was discharged home on anticoagulation with plans for follow up in several clinic Unsure if any relation to vaccine, however, given relatively close temporal relationship, will report out of an abundance of caution.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/11, Pfizer, dose #1 03/04, Pfizer, dose #2 11/02 COVID swab, result: detected 11/02 pt cc: cough exposure: unknown 11/12 clinically resolved
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/11, Pfizer, dose #1 04/06, Pfizer, dose #2 11/05/ COVID swab, result: detected 11/05 pt cc: exposure: unknown 11/15 COVID swab, result: NOTdetected
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: C-reactive protein increased, COVID-19, Headache, Prothrombin time normal, Red blood cell sedimentation rate increased
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/08, Moderna , dose #1 03/08, Moderna , dose #2 10/25 pt/inr: 11.13/1.01 10/25 COVID swab, result: not detected 10/29 CRP: 1.948 10/29 ESR: 3 11/05 COVID swab, result: detected 11/05 pt cc: HEADACHE exposure: unknown
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/08, Moderna , dose #1 03/08, Moderna , dose #2 10/25 pt/inr: 11.13/1.01 10/25 COVID swab, result: not detected 10/29 CRP: 1.948 10/29 ESR: 3 11/05 COVID swab, result: detected 11/05 pt cc: HEADACHE exposure: unknown
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Diarrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/20, Pfizer, dose #1 02/10, Pfizer, dose #2 10/15, Pfizer, dose #3 11/05 COVID swab, result: detected 11/05 pt cc: cough, diarrhea exposure: unknown
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram pulmonary normal, COVID-19, Chest X-ray normal, Cough, Mental status changes
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/16, Pfizer, dose #1 02/05, Pfizer, dose #2 11/08 pt admit to Medicine cc: Cough, congestion, low grade fever and change in mental status dx: COVID19 illness, mild without hypoxia or PNA LOS: 6 days 11/08 COVID swab, result: detected 11/08 pt cc: exposure: unknown 11/08 CTA PE: impression: Segmental and subsegmental pulmonary arteries cannot be confidently evaluated. Otherwise, no acute pulmonary embolism or other convincing acute abnormality in the chest. 11/08 CXR impression: No acute cardiopulmonary abnormality.
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/16, Pfizer, dose #1 02/05, Pfizer, dose #2 11/08 pt admit to Medicine cc: Cough, congestion, low grade fever and change in mental status dx: COVID19 illness, mild without hypoxia or PNA LOS: 6 days 11/08 COVID swab, result: detected 11/08 pt cc: exposure: unknown 11/08 CTA PE: impression: Segmental and subsegmental pulmonary arteries cannot be confidently evaluated. Otherwise, no acute pulmonary embolism or other convincing acute abnormality in the chest. 11/08 CXR impression: No acute cardiopulmonary abnormality.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Cough, Myalgia
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/16, Pfizer, dose #1 04/07, Pfizer, dose #2 11/09 COVID swab, result: detected 10/30 pt cc: cough, loss of taste or smell, myalgias, rhinorrhea, exposure: unknown 11/10 clinically resolved
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/16, Pfizer, dose #1 04/07, Pfizer, dose #2 11/09 COVID swab, result: detected 10/30 pt cc: cough, loss of taste or smell, myalgias, rhinorrhea, exposure: unknown 11/10 clinically resolved
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Cough, Dyspnoea
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/09, Pfizer, dose #1 03/02, Pfizer, dose #2 10/14, Pfizer, dose #3 11/08 COVID swab, result: detected 11/07 pt cc: cough, fatigue, fever, headache, loss of taste or smell, myalgias, dyspnea exposure: unknown 11/08 SARS-COV-2 Variant Sequencing result: pending 11/17 clinically resolved
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/09, Pfizer, dose #1 03/02, Pfizer, dose #2 10/14, Pfizer, dose #3 11/08 COVID swab, result: detected 11/07 pt cc: cough, fatigue, fever, headache, loss of taste or smell, myalgias, dyspnea exposure: unknown 11/08 SARS-COV-2 Variant Sequencing result: pending 11/17 clinically resolved
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Intertrigo, Rash pruritic, Xerosis
Clinical narrative: Narrative:  90 y/o M received Moderna covid-19 booster dose on 10/28/2021. About 3 days after dose, developed a pruritic body rash. Denied fevers, chills. He previously had similar rash exacerbations after first and 2nd Moderna shots (1st dose 1/13/21, 2nd dose 2/10/21), but not as severe. He also had intertrigo and was treated with antifungals. He was referred to dermatology who dx xerosis 4/6, 7/7 and 10/14. Current rash thought possibly exacerbated by the booster dose. Treated with hydroxyzine and prednisone.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac arrest, Death
Clinical narrative: Narrative:  Not reporting a reaction to the vaccine. Reporting VAER as required for pt who received COVID vaccine and passed away some time after receiving the vaccine. Pt passed away months after receiving COVID vaccine d/t other causes (likely cardiac arrest per report).
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  77yo pt died at home in home hospice on 11/11/2021. Pt was discharge from inpatient care to home hospice care on 10/27/2021 due to PATIENT HAS BEEN DEEMED TO HIGH A RISK FOR ANY CARDIAC INTERVENTION including TAVER. Pt also with the following issues: SEVERE AORTIC STENOSIS SEVERE CHRONIC SYSTOLIC HEART FAILURE COPD ACUTE ANEMIA 2O TO GROSS HEMATURIA 2o TO URINARY BLADDER TUMOR SMALL ACUTE PE Pt had received covid vaccines on 3/22/21 & 4/20/21. Death is not related to covid vaccines given hospice diagnosis prior to death.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Lip swelling, SARS-CoV-2 test negative
Clinical narrative: Narrative:  01/11 COVID vaccine dose #1-no reaction 02/09 COVID vaccine dose #2-no reaction 11/10 COVID vaccine dose #3 @11:02am and was monitored for 15 minutes then left the clinic. Pt returned to clinic at 12:10pm and stated that his right upper lip felt puffy and slightly numb. There was no change of color to his skin on his right upper lip/cheek. No visible puffiness/swelling observed on upper right lip/cheek. Pt sat in the normal monitoring station for an addition 30 minutes, drank water and stated the symptoms were much better before leaving.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/02, Pfizer, dose #1 outside LOCAL PHARM 03/02, Pfizer, dose #2 outside LOCAL PHARM 04/10 COVID swab, result NOT detected 10/18 COVID swab, result: detected 10/20 pt cc: exposure: unknown
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Blood fibrinogen increased, Blood lactic acid decreased, Brain natriuretic peptide normal, COVID-19, COVID-19 pneumonia
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 05/20 Janssen, dose #1 09/23 human metapneumovirus: detect 10/13 CXR impression: No acute findings in the chest 10/18 COVID swab, result: detected 10/18 pt cc: cough, diarrhea, fatigue, fever, rhinorrhea myalgias, sore throat, sinus and chest congestion exposure: unknown 10/18 BNP: 16.8 10/18 SARS-COV-2 Variant Sequencing result: pending 10/18 LACTIC ACID: 0.88 10/18 CXR impression: Streaky peribronchial opacities emanating from both hila may reflect ongoing bronchitis. No pneumonia, pleural effusion or solid mass. 1027 pt admit cc: dyspnea, dry cough, and malaise dx: covid infection, pneumonia LOS: 4 days 10/27 TROPONIN I: <0.016 10/27 BNP: 44.0 10/27 FIBRINOGEN: 602 10/27 DDIMER: 0.49 10/27 FERRITIN: 433.8 10/27 LACTIC ACID: 1.59 10/27 PROCALCITONIN: <0.05 10/27 CXR impression: impression: Bilateral lung opacities would be consistent with COVID pneumonia in the reported clinical setting. 10/28 FIBRINOGEN: 555 10/28 DDIMER: 0.43 10/28 ESR: 55 10/29 FIBRINOGEN: 503 10/29 DDIMER: 0.42 10/29 ESR: 47 10/30 FIBRINOGEN: 414 10/30 DDIMER: 0.37 10/30 ESR: 38
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Cough, Diarrhoea, Dyspnoea, Fatigue
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 05/20 Janssen, dose #1 09/23 human metapneumovirus: detect 10/13 CXR impression: No acute findings in the chest 10/18 COVID swab, result: detected 10/18 pt cc: cough, diarrhea, fatigue, fever, rhinorrhea myalgias, sore throat, sinus and chest congestion exposure: unknown 10/18 BNP: 16.8 10/18 SARS-COV-2 Variant Sequencing result: pending 10/18 LACTIC ACID: 0.88 10/18 CXR impression: Streaky peribronchial opacities emanating from both hila may reflect ongoing bronchitis. No pneumonia, pleural effusion or solid mass. 1027 pt admit cc: dyspnea, dry cough, and malaise dx: covid infection, pneumonia LOS: 4 days 10/27 TROPONIN I: <0.016 10/27 BNP: 44.0 10/27 FIBRINOGEN: 602 10/27 DDIMER: 0.49 10/27 FERRITIN: 433.8 10/27 LACTIC ACID: 1.59 10/27 PROCALCITONIN: <0.05 10/27 CXR impression: impression: Bilateral lung opacities would be consistent with COVID pneumonia in the reported clinical setting. 10/28 FIBRINOGEN: 555 10/28 DDIMER: 0.43 10/28 ESR: 55 10/29 FIBRINOGEN: 503 10/29 DDIMER: 0.42 10/29 ESR: 47 10/30 FIBRINOGEN: 414 10/30 DDIMER: 0.37 10/30 ESR: 38
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Fibrin D dimer increased, Lung opacity, Malaise, Myalgia, Oropharyngeal pain
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 05/20 Janssen, dose #1 09/23 human metapneumovirus: detect 10/13 CXR impression: No acute findings in the chest 10/18 COVID swab, result: detected 10/18 pt cc: cough, diarrhea, fatigue, fever, rhinorrhea myalgias, sore throat, sinus and chest congestion exposure: unknown 10/18 BNP: 16.8 10/18 SARS-COV-2 Variant Sequencing result: pending 10/18 LACTIC ACID: 0.88 10/18 CXR impression: Streaky peribronchial opacities emanating from both hila may reflect ongoing bronchitis. No pneumonia, pleural effusion or solid mass. 1027 pt admit cc: dyspnea, dry cough, and malaise dx: covid infection, pneumonia LOS: 4 days 10/27 TROPONIN I: <0.016 10/27 BNP: 44.0 10/27 FIBRINOGEN: 602 10/27 DDIMER: 0.49 10/27 FERRITIN: 433.8 10/27 LACTIC ACID: 1.59 10/27 PROCALCITONIN: <0.05 10/27 CXR impression: impression: Bilateral lung opacities would be consistent with COVID pneumonia in the reported clinical setting. 10/28 FIBRINOGEN: 555 10/28 DDIMER: 0.43 10/28 ESR: 55 10/29 FIBRINOGEN: 503 10/29 DDIMER: 0.42 10/29 ESR: 47 10/30 FIBRINOGEN: 414 10/30 DDIMER: 0.37 10/30 ESR: 38
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Procalcitonin normal, Pyrexia, Red blood cell sedimentation rate increased, Respiratory tract congestion, Rhinorrhoea
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 05/20 Janssen, dose #1 09/23 human metapneumovirus: detect 10/13 CXR impression: No acute findings in the chest 10/18 COVID swab, result: detected 10/18 pt cc: cough, diarrhea, fatigue, fever, rhinorrhea myalgias, sore throat, sinus and chest congestion exposure: unknown 10/18 BNP: 16.8 10/18 SARS-COV-2 Variant Sequencing result: pending 10/18 LACTIC ACID: 0.88 10/18 CXR impression: Streaky peribronchial opacities emanating from both hila may reflect ongoing bronchitis. No pneumonia, pleural effusion or solid mass. 1027 pt admit cc: dyspnea, dry cough, and malaise dx: covid infection, pneumonia LOS: 4 days 10/27 TROPONIN I: <0.016 10/27 BNP: 44.0 10/27 FIBRINOGEN: 602 10/27 DDIMER: 0.49 10/27 FERRITIN: 433.8 10/27 LACTIC ACID: 1.59 10/27 PROCALCITONIN: <0.05 10/27 CXR impression: impression: Bilateral lung opacities would be consistent with COVID pneumonia in the reported clinical setting. 10/28 FIBRINOGEN: 555 10/28 DDIMER: 0.43 10/28 ESR: 55 10/29 FIBRINOGEN: 503 10/29 DDIMER: 0.42 10/29 ESR: 47 10/30 FIBRINOGEN: 414 10/30 DDIMER: 0.37 10/30 ESR: 38
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Serum ferritin increased, Sinus congestion, Troponin I normal
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 05/20 Janssen, dose #1 09/23 human metapneumovirus: detect 10/13 CXR impression: No acute findings in the chest 10/18 COVID swab, result: detected 10/18 pt cc: cough, diarrhea, fatigue, fever, rhinorrhea myalgias, sore throat, sinus and chest congestion exposure: unknown 10/18 BNP: 16.8 10/18 SARS-COV-2 Variant Sequencing result: pending 10/18 LACTIC ACID: 0.88 10/18 CXR impression: Streaky peribronchial opacities emanating from both hila may reflect ongoing bronchitis. No pneumonia, pleural effusion or solid mass. 1027 pt admit cc: dyspnea, dry cough, and malaise dx: covid infection, pneumonia LOS: 4 days 10/27 TROPONIN I: <0.016 10/27 BNP: 44.0 10/27 FIBRINOGEN: 602 10/27 DDIMER: 0.49 10/27 FERRITIN: 433.8 10/27 LACTIC ACID: 1.59 10/27 PROCALCITONIN: <0.05 10/27 CXR impression: impression: Bilateral lung opacities would be consistent with COVID pneumonia in the reported clinical setting. 10/28 FIBRINOGEN: 555 10/28 DDIMER: 0.43 10/28 ESR: 55 10/29 FIBRINOGEN: 503 10/29 DDIMER: 0.42 10/29 ESR: 47 10/30 FIBRINOGEN: 414 10/30 DDIMER: 0.37 10/30 ESR: 38
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series Q05/14 Janssen, dose #1 10/23 COVID swab, result: detected 10/23 pt cc: exposure: unknown
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dyspnoea, Fatigue, Headache
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/18, Pfizer, dose #1 04/09, Pfizer, dose #2 10/25 COVID swab, result: detected 10/25 pt cc: rhinorrhea, cough, headache, dyspnea, fatigue, exposure: unknown 10/25 SARS-COV-2 Variant Sequencing result: pending 11/4 clinically resolved
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/18, Pfizer, dose #1 04/09, Pfizer, dose #2 10/25 COVID swab, result: detected 10/25 pt cc: rhinorrhea, cough, headache, dyspnea, fatigue, exposure: unknown 10/25 SARS-COV-2 Variant Sequencing result: pending 11/4 clinically resolved
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Computerised tomogram thorax abnormal, International normalised ratio normal, Lung consolidation, Lung opacity
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/15, Pfizer, dose #1 02/05, Pfizer, dose #2 09/24 , Pfizer, dose #3 08/16 BinaxNOW COVID-19 Ag: NOT DETECTED 08/17 CT CHEST W/O IMPRESSION: Continued stability of multiple tree-in-bud opacities and nodular consolidations in the left upper and lower lobes. No new suspicious findings. 09/13 BinaxNOW COVID-19 Ag: NOT DETECTED 09/16 BinaxNOW COVID-19 Ag: NOT DETECTED  09/23 BinaxNOW COVID-19 Ag: NOT DETECTED 09/27 BinaxNOW COVID-19 Ag: NOT DETECTED 09/30 BinaxNOW COVID-19 Ag: NOT DETECTED 10/04 BinaxNOW COVID-19 Ag: NOT DETECTED 10/07 BinaxNOW COVID-19 Ag: NOT DETECTED 10/12 BinaxNOW COVID-19 Ag: NOT DETECTED 10/27 PT/INR: 12.2/1.09 10/27 COVID swab, result: detected 10/27 pt cc: exposure: unknown
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Prothrombin time normal, Pulmonary mass, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/15, Pfizer, dose #1 02/05, Pfizer, dose #2 09/24 , Pfizer, dose #3 08/16 BinaxNOW COVID-19 Ag: NOT DETECTED 08/17 CT CHEST W/O IMPRESSION: Continued stability of multiple tree-in-bud opacities and nodular consolidations in the left upper and lower lobes. No new suspicious findings. 09/13 BinaxNOW COVID-19 Ag: NOT DETECTED 09/16 BinaxNOW COVID-19 Ag: NOT DETECTED  09/23 BinaxNOW COVID-19 Ag: NOT DETECTED 09/27 BinaxNOW COVID-19 Ag: NOT DETECTED 09/30 BinaxNOW COVID-19 Ag: NOT DETECTED 10/04 BinaxNOW COVID-19 Ag: NOT DETECTED 10/07 BinaxNOW COVID-19 Ag: NOT DETECTED 10/12 BinaxNOW COVID-19 Ag: NOT DETECTED 10/27 PT/INR: 12.2/1.09 10/27 COVID swab, result: detected 10/27 pt cc: exposure: unknown
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Chills, Cough, Diarrhoea
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/23, Pfizer, dose #1 03/16, Pfizer, dose #2 08/02 COVID swab, result: NOT detected 08/19 pt cc: chills, cough, diarrhea, fatigue, fever, myalgias, rhinorrhea, dyspnea exposure: unknown 10/26 COVID swab, result: detected 10/26 clinically resolved 11/01 COVID swab, result: detected 11/01 CXR impression: No acute cardiopulmonary disease. 11/01 US EXTREMITY VENOUS impression: No evidence of LEFT lower extremity DVT. 11/01 human rhinovirus: detected
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Human rhinovirus test positive, Myalgia, Pyrexia
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/23, Pfizer, dose #1 03/16, Pfizer, dose #2 08/02 COVID swab, result: NOT detected 08/19 pt cc: chills, cough, diarrhea, fatigue, fever, myalgias, rhinorrhea, dyspnea exposure: unknown 10/26 COVID swab, result: detected 10/26 clinically resolved 11/01 COVID swab, result: detected 11/01 CXR impression: No acute cardiopulmonary disease. 11/01 US EXTREMITY VENOUS impression: No evidence of LEFT lower extremity DVT. 11/01 human rhinovirus: detected
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive, Ultrasound Doppler normal
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/23, Pfizer, dose #1 03/16, Pfizer, dose #2 08/02 COVID swab, result: NOT detected 08/19 pt cc: chills, cough, diarrhea, fatigue, fever, myalgias, rhinorrhea, dyspnea exposure: unknown 10/26 COVID swab, result: detected 10/26 clinically resolved 11/01 COVID swab, result: detected 11/01 CXR impression: No acute cardiopulmonary disease. 11/01 US EXTREMITY VENOUS impression: No evidence of LEFT lower extremity DVT. 11/01 human rhinovirus: detected
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/12, MODERNA, dose #1 outside facility 04/30, MODERNA, dose #2 outside facility 10/27 COVID swab, result: detected 10/27 pt cc: exposure: unknown
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Influenza like illness, Pyrexia
Clinical narrative: Headache, Fever, flu-like symptoms Narrative:
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site swelling, Myalgia, Rash
Clinical narrative: Myalgia, SkinRash, Rash, raised red area at injection site Narrative:
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Myalgia
Clinical narrative: Headache & Myalgia Narrative: referred to PCP if sx worsen or persist
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Musculoskeletal stiffness, Myalgia, Pyrexia
Clinical narrative: Headache, Myalgia, Fever, stiff neck, fatigue Narrative: N/A
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Emotional distress, Headache, Nausea, Vomiting
Clinical narrative: Headache, NauseaVomiting, Initial BP taken was 97/72 with HR 94. BP upon leaving clinic was 108/79, HR 93.  Narrative: Employee stated that she had the same reaction(N/V and HA) with the 1st Moderna vaccine as well. No airway issues noted. Pt did not want to be sent to ER. Reiterated to employee to see emergent care of any airway symptoms were to appear or she worsened. Employee still felt nauseous upon leaving the clinic. She did note that with the reaction she had to the 1st Moderna vaccine she had vomiting as well. No vomiting noted during this event.Employee was in no acute distress and exited the clinic pre steady gait ambulation to speak with her supervisor and visit her PCP.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Immunisation reaction, Injection site erythema, Injection site pruritus, Myalgia
Clinical narrative: Myalgia, Fever, Chills and myalgias x 36 hrs Narrative: developed redness/itching (no hives) well demarcated ~2" away from injection site, not cellulititic,? delayed COVID "arm"
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Myalgia, Fever, Chills and myalgias x 36 hrs Narrative: developed redness/itching (no hives) well demarcated ~2" away from injection site, not cellulititic,? delayed COVID "arm"
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Pyrexia
Clinical narrative: Myalgia, Fever, fatigue Narrative:
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Loss of personal independence in daily activities, Mobility decreased, Pain
Clinical narrative: Two days after second Covid-19 vaccination I experienced moderate generalized pain concentrated in major joints which affected daily activities and movement. Pain was 5-6 on 10 point scale and lasted approximately one month.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness
Clinical narrative: severe dizziness; Headache; Sore arm; This is a spontaneous report from a contactable consumer (patient). A 49-years-old female patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection, Lot Number: ER8734), via an unspecified route of administration, administered in Arm Left on 31Mar2021 10:00 (at the age of 49years) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included hypersensitivity from an unknown date and unknown if ongoing( Known allergies :avocado). Concomitant medication included ascorbic acid, betacarotene, biotin, calcium lactate, choline bitartrate, chromium nicotinate, colecalciferol, cyanocobalamin, dexpanthenol, dl-selenomethionine, folic acid, inositol, magnesium lactate, manganese gluconate, nicotinamide, potassium citrate, potassium iodide, pyridoxine hydrochloride, retinol palmitate, riboflavin phosphate, thiamine hydrochloride, tocopheryl acetate, zinc gluconate (MULTI VITAMIN & MINERAL) taken for an unspecified indication, start and stop date were not reported.  The patient previously took sulfa [sulfacetamide sodium;sulfadiazine;sulfadimidine;sulfamerazine] and experienced drug hypersensitivity. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 01Apr2021 06:00, the patient experienced severe dizziness, headache, and sore arm. The patient woke up on 01Apr2021 with severely dizzy. This continued for 2.50 weeks 24/7. The only time she felt ok was laying down. It started to get better in time for her second dose. After second dose it didn't get worse. Only a headache in the middle of the night and a sore arm for about a week. The dizziness has not gone away completely and today is 14May2021. The patient went to the Dr on 06Apr2021, was prescribed Meclizine, doesn't seem to be working. Have also been taking a claritin daily. The outcome of the event dizziness was not recovered and the other events was recovered on an unknown date in Apr2021.  Follow-up attempts are completed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Headache, Pain in extremity
Clinical narrative: severe dizziness; Headache; Sore arm; This is a spontaneous report from a contactable consumer (patient). A 49-years-old female patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection, Lot Number: ER8734), via an unspecified route of administration, administered in Arm Left on 31Mar2021 10:00 (at the age of 49years) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included hypersensitivity from an unknown date and unknown if ongoing( Known allergies :avocado). Concomitant medication included ascorbic acid, betacarotene, biotin, calcium lactate, choline bitartrate, chromium nicotinate, colecalciferol, cyanocobalamin, dexpanthenol, dl-selenomethionine, folic acid, inositol, magnesium lactate, manganese gluconate, nicotinamide, potassium citrate, potassium iodide, pyridoxine hydrochloride, retinol palmitate, riboflavin phosphate, thiamine hydrochloride, tocopheryl acetate, zinc gluconate (MULTI VITAMIN & MINERAL) taken for an unspecified indication, start and stop date were not reported.  The patient previously took sulfa [sulfacetamide sodium;sulfadiazine;sulfadimidine;sulfamerazine] and experienced drug hypersensitivity. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 01Apr2021 06:00, the patient experienced severe dizziness, headache, and sore arm. The patient woke up on 01Apr2021 with severely dizzy. This continued for 2.50 weeks 24/7. The only time she felt ok was laying down. It started to get better in time for her second dose. After second dose it didn't get worse. Only a headache in the middle of the night and a sore arm for about a week. The dizziness has not gone away completely and today is 14May2021. The patient went to the Dr on 06Apr2021, was prescribed Meclizine, doesn't seem to be working. Have also been taking a claritin daily. The outcome of the event dizziness was not recovered and the other events was recovered on an unknown date in Apr2021.  Follow-up attempts are completed. No further information is expected.